These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2387259)

  • 1. Effect of extended exposure to hypertonicity on vasopressin messenger ribonucleic acid content in hypothalamo-neurohypophyseal explants.
    Yagil C; Sladek CD
    Endocrinology; 1990 Sep; 127(3):1428-35. PubMed ID: 2387259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic regulation of vasopressin and oxytocin release is rate sensitive in hypothalamoneurohypophysial explants.
    Yagil C; Sladek CD
    Am J Physiol; 1990 Feb; 258(2 Pt 2):R492-500. PubMed ID: 2309938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotic control of vasopressin release by rat hypothalamo-neurohypophyseal explants in organ culture.
    Sladek CD; Knigge KM
    Endocrinology; 1977 Dec; 101(6):1834-8. PubMed ID: 590195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of noradrenergic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system.
    Armstrong WE; Sladek CD; Sladek JR
    Endocrinology; 1982 Jul; 111(1):273-9. PubMed ID: 7084115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anteroventral third ventricle lesions on vasopressin release by organ-cultured hypothalamo-neurohypophyseal explants.
    Sladek CD; Johnson AK
    Neuroendocrinology; 1983 Jul; 37(1):78-84. PubMed ID: 6888661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-Aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants.
    Sladek CD; Armstrong WE
    Endocrinology; 1987 Apr; 120(4):1576-80. PubMed ID: 2435537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic involvement in osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system.
    Sladek CD; Joynt RJ
    Endocrinology; 1979 Aug; 105(2):367-71. PubMed ID: 456315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of non-NMDA receptors in osmotic and glutamate stimulation of vasopressin release: effect of rapid receptor desensitization.
    Sladek CD; Badre SE; Morsette DJ; Sidorowicz HE
    J Neuroendocrinol; 1998 Dec; 10(12):897-903. PubMed ID: 9870746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal steroid modulation of vasopressin secretion in response to osmotic stimulation.
    Swenson KL; Sladek CD
    Endocrinology; 1997 May; 138(5):2089-97. PubMed ID: 9112409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP regulation of vasopressin mRNA content in hypothalamo-neurohypophysial explants.
    Sladek CD; Fisher KY; Sidorowicz HE; Mathiasen JR
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R554-60. PubMed ID: 8853375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy, and lactation.
    Van Tol HH; Bolwerk EL; Liu B; Burbach JP
    Endocrinology; 1988 Mar; 122(3):945-51. PubMed ID: 3342761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin in the osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system.
    Sladek CD; Joynt RJ
    Endocrinology; 1980 Jan; 106(1):173-8. PubMed ID: 7349952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid changes in poly (A) tail length of vasopressin and oxytocin mRNAs form a common early component of neurohypophyseal peptide gene activation following physiological stimulation.
    Carter DA; Murphy D
    Neuroendocrinology; 1991 Jan; 53(1):1-6. PubMed ID: 1675437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholinergic antagonists on basal and osmotically stimulated vasopressin release in compartmentalized hypothalamo-neurohypophysial explants.
    Gregg CM
    Neuroendocrinology; 1986; 44(3):378-83. PubMed ID: 2880306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin stimulation of vasopressin release from the rat hypothalamo-neurohypophyseal system in organ culture.
    Sladek CD; Joynt RJ
    Endocrinology; 1979 Jan; 104(1):148-53. PubMed ID: 446341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin modulates oxytocin mRNA during lactation by its action on the hypothalamo-neurohypophyseal axis.
    Ghosh R; Sladek CD
    Brain Res; 1995 Feb; 672(1-2):24-8. PubMed ID: 7749745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinoaortic denervation alters the molecular and endocrine responses to salt loading.
    Rocha MJ; Callahan MF; Sundberg DK; Morris M
    Neuroendocrinology; 1993 Apr; 57(4):729-37. PubMed ID: 8367035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses in vasopressin and oxytocin gene expression in distinct hypothalamic nuclei after hypothalamoneurohypophyseal disconnection and vasopressin substitution.
    Van Tol HH; Kiss JZ; Burbach JP
    Neuroendocrinology; 1989 Apr; 49(4):337-43. PubMed ID: 2716958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release.
    Gregg CM; Sladek CD
    Neuroendocrinology; 1984 May; 38(5):397-402. PubMed ID: 6728121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.